Sprint Bioscience AB
F:5JA1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sprint Bioscience AB
F:5JA1
|
SE |
|
H
|
HD Hyundai Co Ltd
KRX:267250
|
KR |
|
A
|
Anheuser Busch Inbev SA
F:ITKA
|
BE |
|
Omnicell Inc
NASDAQ:OMCL
|
US |
|
T
|
Titan International Inc
XBER:TZ4
|
US |
|
A
|
Allegion PLC
F:60A
|
IE |
|
R
|
Reinet Investments SCA
F:RNT
|
LU |
|
A
|
American Homes 4 Rent
F:A4XA
|
US |
|
R
|
RH
XBER:RS1
|
US |
|
A
|
Allianz SE
XBER:ALV
|
DE |
|
Commonwealth Bank of Australia
ASX:CBA
|
AU |
|
Zai Lab Ltd
F:1ZL
|
CN |
|
N
|
NOA Lithium Brines Inc
XTSX:NOAL
|
CA |
|
W
|
Walgreens Boots Alliance Inc
LSE:0LSZ
|
US |
|
T
|
Talanx AG
XHAM:TLX
|
DE |
|
D
|
Deluxe Corp
XBER:DL8
|
US |
|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
|
US |
|
Northeast Community Bancorp Inc
NASDAQ:NECB
|
US |
|
Gurit Holding AG
LSE:0QQR
|
CH |
|
Granite Construction Inc
NYSE:GVA
|
US |
Bankruptcy Probability
Sprint Bioscience AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sprint Bioscience AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
S
|
Sprint Bioscience AB
STO:SPRINT
|
379.9m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
176.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
239.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sprint Bioscience AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sprint Bioscience AB has no debt.
You can find a full breakdown on its Balance Sheet.
